Medical Monitoring Provider Dexcom's Stock Drops 40% as Q2 Revenue Misses Estimates, Lowers Full-Year Guidance

  • last month
Dexcom's stock plunged nearly 40% after the company reported second-quarter revenue that missed estimates and lowered its full-year guidance.

Recommended